This personalized pacing is key to long-term adherence
Until there is evidence from high-quality postmarketing studies, the FDA should consider updating labeling to advise caution on generalizing the safety and effectiveness of GLP-1 and GLP-1/GIP to populations excluded from pivotal trials. Limitations to wider generalizability of these findings are the self-reported nature of the participants medical conditions and the investigators inability to accurately measure all exclusion criteria, which lends itself to potential for underestimation
Not every patient is a candidate, and not every peptide is appropriate for every patient
Ferrell PB Jr, McLeod HL (2008) Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
Niacinamide (Vitamin B3): A high-purity skin-perfecting vitamin that refines pore structure, improves overall skin elasticity, and balances irregular texture for a smoother look
We do not manufacture, prescribe, or dispense medication directly